Authors


Erik Hefti, PharmD, MS, PhD

Latest:

Considerations for Pharmacists Practicing in Dedicated COVID-19 Treatment Facilities

Each patient represents a unique set of challenges that requires focus and knowledge.




Gulcin Gumus, PhD

Latest:

Quantitative Analysis of 2 Treatment Options for Osteoarthritis in Adults: Intra-Articular Hyaluronan Products and Diacerein

Empirical findings suggest that hyaluronan injections and diacerein are similarly effective. Yet the authors found that monetary savings could be realized when conservative treatment with diacerein is chosen.


Jonathan D. Cicci, PharmD, BCPS

Latest:

Venothromboembolism: Treatment Recommendations and Therapeutic Options

Venothromboembolism has an annual incidence of 1 or 2 cases per 1000 individuals and is the third most common cause of vascular death.


John Coster, PhD, RPh

Latest:

Health Care Reform's Impact on Community Pharmacy

The Coalition for Community Pharmacy Action (CCPA) has been working toward ensuring that health care reform legislation favors community pharmacies-included here are some top issues and when the change will take effect.


Joseph L. Fink III, BSPharm, JD

Latest:

340B Assists Patients and Institutions

How much does this federal program affect the success of the health care parties involved?



Neetu V. Agashivala, MS

Latest:

Cost-Effectiveness of Fingolimod in Treating Patients With Relapsing-Remitting Multiple Sclerosis

Fingolimod, a first-line, once-daily oral disease-modifying therapy for relapsing-remitting multiple sclerosis, has the lowest cost per relapse avoided compared with other first-line agents.


Chelsey Lindner, PharmD, BCOP

Latest:

Assessing the Landscape of HER2+ Breast Cancer Treatment

New therapies and combination regimens may allow a more tailored approach.





Julie A. Stading, PharmD, CDE

Latest:

Controlling Diabetes: Teaching Patients to Take Charge

The American Diabetes Association recommends that health care providers incorporate an estimated average glucose measurement when counseling patients with diabetes.


Reina Benabou, MD, PhD

Latest:

Promoting Brain Function Is Key Amid COVID-19 Crisis

Necessary measures taken during the pandemic may exacerbate some underlying factors that can lead to decline.


Mohammad Waleed, PharmD Candidate

Latest:

Patients Are Increasingly at Risk for Insulin-Drug Interactions

Health Care Professionals Should Be Aware of Classes of Medications and Conditions That May Affect Blood Glucose Levels.



Claudia Uribe, MD, PhD

Latest:

Impact of Insulin Delivery Systems in Elderly Patients With Type 2 Diabetes

This real-world study suggests that improved clinical outcomes are possible in the difficult-to-treat elderly patients with type 2 diabetes group without affecting healthcare costs, by initiating insulin therapy with a pen device.


Parisa Vatanka, PharmD, CTTS

Latest:

New Technologies Boost Pharmacist's Role

Digital health products and solutions expand ways to guide prevention and treatment.


Meaghan Murphy, PharmD, BCACP

Latest:

A Collaborative Approach to Specialty Pharmacy at an Academic Medical Center

The SUNY Outpatient Pharmacy has developed a strong collaboration with specialty pharmacy personnel and clinically embedded pharmacists.



Suzette Rovelsky, PharmD

Latest:

A Call to Action for Evidence-based, Outcomes-driven Conflict Management Styles

With expanding pharmacy practice, it is time to explore conflict management, and its necessity in this current climate.


Susan R. Winkler, PharmD

Latest:

The Road Less Traveled: Nontraditional Work Arrangements in Academia

According to the 2014 National Pharmacist Workforce Study, approximately 18.7% of women and 16.4% of men actively engaged as pharmacists reported working part-time.



Steven Taylor

Latest:

A Patient's Voice Is Like No Other

The pharmacy benefits industry can learn ways to streamline processes, make cost-effective changes, and increase efficiency by listening to patients with chronic illness.


Donald R. Miller, ScD

Latest:

Potentially Inappropriate Prescribing of Direct-acting Oral Anticoagulants in the Veterans Health Administration

This study examines variations in overall use, and potentially inappropriate use, of non-warfarin direct-acting oral anticoagulants across sites within the Veterans Health Administration.


Troy Shirley, PharmD, MBA

Latest:

Outpatient Cancer Center Cost Evaluation of Extended Beyond-Use Dating with a Closed-System Transfer Device

There is a constant balancing act for health care systems to provide the newest and most up-to-date care for patients while being financially responsible.



Kaitlyn K. Frick

Latest:

Legislation Aims to Protect Children With Severe Allergies

Push continues for more access to EpiPens, but it is important to protect health care providers who administer the treatment.